{
  "context": {
    "rules": [
      "Rule1: If the lab facility is approved by the FDA, then it follows good manufacturing practices.",
      "Rule2: In the event that the experimental drug passes quality control, it is not the case that it meets specifications.",
      "Rule3: Whenever the experimental drug fails the safety test, it does not hold that it is rejected.",
      "Rule4: Either the experimental drug fails the safety test or it fails the efficacy test.",
      "Rule5: Under the condition that the experimental drug fails the efficacy test, it is not rejected.",
      "Rule6: If the production manager has FDA clearance, then if it is not the case that if it is not the case that if the lab facility does not follow good manufacturing practices then the experimental drug requires retesting, then it is not scheduled for retest, then it is not the case that the experimental drug is approved for production.",
      "Rule7: Given that the lab facility has a research license authorization, it is approved by the FDA.",
      "Rule8: The lab facility has a research license authorization, or the lab technician has safety training certification.",
      "Rule9: Provided that the experimental drug has patent protection, it is eligible for fast track.",
      "Rule10: Whenever the experimental drug is eligible for fast track, then either it is classified as an orphan drug, or if it is not the case that if the lab facility does not follow good manufacturing practices then the experimental drug does not contain a controlled substance, then it requires a special permit.",
      "Rule11: If the lab facility is compliant with regulations, then it follows good manufacturing practices.",
      "Rule12: In the event that the lab facility is undergoing an audit, it passes the audit.",
      "Rule13: Either the lab facility is undergoing an audit, or if the lab technician has safety training certification, then the lab facility is approved by the FDA.",
      "Rule14: Whenever the lab facility has violations, it is fined.",
      "Rule15: The lab facility has violations, or if it is undergoing an audit, then it does not pass the audit.",
      "Rule16: The lab facility is operating normally, or it is reported to authorities, or if it is not approved by the FDA, then it is operating illegally.",
      "Rule17: Provided that the reactor vessel has an equipment malfunction, the lab facility is not operating normally.",
      "Rule18: Either the reactor vessel has an equipment malfunction, or it is scheduled for maintenance.",
      "Rule19: Under the condition that the reactor vessel is scheduled for maintenance, it is inspected.",
      "Rule20: Whenever the reactor vessel is repaired, the lab facility is not operating normally.",
      "Rule21: If the reactor vessel is calibrated, then it is repaired.",
      "Rule22: In the event that the lab technician is qualified for chemical handling, the lab facility is approved by the FDA.",
      "Rule23: Under the condition that the quality manager follows the protocol, then if the reactor vessel is inspected, it is calibrated.",
      "Rule24: Should the raw material be from a fresh supply, then it is not expired.",
      "Rule25: Either the raw material is from a fresh supply, or it is properly stored.",
      "Rule26: Provided that the chemical company is a verified supplier, then if the raw material is tested pure, it is suitable for use.",
      "Rule27: The chemical company is a verified supplier, or it is a certified supplier.",
      "Rule28: In the event that the chemical company is a certified supplier, then if the raw material is tested pure, it is suitable for use.",
      "Rule29: Under the condition that the waste material is a toxic byproduct, it requires special disposal.",
      "Rule30: Either the waste material is a toxic byproduct, or it is a hazardous byproduct.",
      "Rule31: Whenever the waste material is a hazardous byproduct, the experimental drug is not rejected.",
      "Rule32: Either the chemical sample is contaminated, or if the lab technician has safety training certification, then they are qualified for chemical handling.",
      "Rule33: Provided that the lab facility has a disposal permit, then if the waste material requires special disposal, the experimental drug is not rejected.",
      "Rule34: Either the lab facility has a disposal permit, or it has a contracted disposal company.",
      "Rule35: Under the condition that the lab facility is compliant with the EPA, then if it has a contracted disposal company, then if the waste material requires special disposal, the experimental drug is not rejected.",
      "Rule36: Either the lab facility is compliant with the EPA, or it is following protocols.",
      "Rule37: Whenever the chemical container is mislabeled, it is correctly labeled.",
      "Rule38: Either the chemical container is mislabeled, or if the lab facility is following protocols, then if it has a contracted disposal company, then if the waste material requires special disposal, the experimental drug is not rejected.",
      "Rule39: Given that the lab technician identified an error, then if the chemical container is mislabeled, it is not correctly labeled.",
      "Rule40: Either the lab technician identified an error, or they reported an error.",
      "Rule41: Provided that the lab technician reported an error, then if the chemical container is mislabeled, it is not correctly labeled.",
      "Rule42: In the event that the trial for the experimental drug is terminated, it is not recalled from the market.",
      "Rule43: Under the condition that the chemical sample is sterilized, it is not contaminated.",
      "Rule44: Either the chemical sample is sterilized, or it is purified.",
      "Rule45: Whenever the experimental drug is a high-risk drug, it has restricted distribution.",
      "Rule46: Either the experimental drug is a high-risk drug, or it is a controlled access drug.",
      "Rule47: Given that the experimental drug is a controlled access drug, then either it is under surveillance, or if it is a monitored substance, then it does not contain a controlled substance.",
      "Rule48: In the event that the experimental drug requires a prescription, it is not available over the counter.",
      "Rule49: Either the experimental drug is classified under a schedule, or it is a regulated substance.",
      "Rule50: Should the experimental drug be a regulated substance, then if it requires a prescription, it is available over the counter.",
      "Rule51: Whenever the experimental drug is documented properly, then if it is classified under a schedule, then if it requires a prescription, it is available over the counter.",
      "Rule52: Given that the chemical sample is purified, it is not contaminated.",
      "Rule53: Provided that the experimental drug is recorded in the database, then if it is classified under a schedule, then if it requires a prescription, it is available over the counter.",
      "Rule54: In the event that the production schedule meets the deadline, then either the experimental drug is documented properly, or it is recorded in the database.",
      "Rule55: Either the production schedule is on schedule, or if it is accelerated, then it is delayed.",
      "Rule56: Should the experimental drug be properly documented, then if the lab facility does not follow good manufacturing practices, then the experimental drug does not contain a controlled substance.",
      "Rule57: Whenever the experimental drug has approved documentation, it is properly documented.",
      "Rule58: Given that the experimental drug has complete documentation, it is properly documented.",
      "Rule59: In the event that the experimental drug is submitted to the FDA, it is under review.",
      "Rule60: Either the raw material is expired, or the lab facility follows good manufacturing practices.",
      "Rule61: Either the experimental drug passed the initial review, or it requires additional data.",
      "Rule62: Given that the experimental drug requires additional data, then if it is under review, then either it has approved documentation, or it has complete documentation.",
      "Rule63: Provided that the experimental drug is cleared for the next phase, then if it is under review, then either it has approved documentation, or it has complete documentation.",
      "Rule64: Either the experimental drug is fast-tracked, or if it passed the initial review, then it is cleared for the next phase.",
      "Rule65: Should the lab facility be following guidelines, then it is shut down.",
      "Rule66: Either the lab facility has compliant operations, or if it is operating legally, then it is following guidelines.",
      "Rule67: Whenever the lab facility has a renewed license, it has a valid license.",
      "Rule68: Either the lab facility has a renewed license, or it is not a certified lab.",
      "Rule69: Given that the experimental drug is tested, it passes quality control.",
      "Rule70: Either the experimental drug is tested, or the raw material is not expired.",
      "Rule71: In the event that the lab facility is staffed, it is equipped.",
      "Rule72: Whenever the lab facility is supplied, it is operational.",
      "Rule73: Either the lab facility exceeds the standards, or if it meets the requirements, then if it is not the case that if it is equipped then it is supplied, then it is functional.",
      "Rule74: In the event that it is not the case that if the experimental drug passes quality control then it meets specifications, then it is rejected.",
      "Rule75: Provided that it is not the case that if the experimental drug passes quality control then it meets specifications, then it is recalled from the market.",
      "Rule76: Should it not hold that either the lab facility is accredited by an agency or it is compliant with regulations, then it is operating legally.",
      "Rule77: Whenever it is not the case that either the lab facility is accredited by an agency or it is compliant with regulations, then it is a certified lab.",
      "Rule78: Provided that it is not the case that either the lab facility is accredited by an agency or it is compliant with regulations, then it is staffed.",
      "Rule79: In the event that it is not the case that either the lab facility is accredited by an agency or it is compliant with regulations, then it is not shut down.",
      "Rule80: Should it not be the case that if the raw material is properly stored then it is not expired, then it is tested pure.",
      "Rule81: Given that it is not the case that if it is not the case that either the lab facility is accredited by an agency or it is compliant with regulations, then it is shut down, then it is under investigation.",
      "Rule82: Provided that it is not the case that if it is not the case that either the lab facility is accredited by an agency or it is compliant with regulations, then it is shut down, then it is not under investigation.",
      "Rule83: In the event that it is not the case that if it is not the case that if the lab facility does not follow good manufacturing practices then the experimental drug requires retesting, then it is not scheduled for retest, then it is approved for production.",
      "Rule84: Should it not be the case that if the lab facility does not follow good manufacturing practices then the experimental drug requires retesting, then it is scheduled for retest.",
      "Rule85: Provided that it is not the case that if the lab facility does not follow good manufacturing practices then the experimental drug does not contain a controlled substance, then it requires a prescription.",
      "Rule86: Under the condition that the lab facility is not approved by the FDA, it is not operating illegally.",
      "Rule87: Whenever the production schedule does not meet the deadline, it is accelerated.",
      "Rule88: Provided that the lab facility does not follow good manufacturing practices, the experimental drug contains a controlled substance.",
      "Rule89: In the event that the lab facility does not follow good manufacturing practices, the experimental drug is a monitored substance."
    ],
    "facts": [
      "Fact1: The production manager has FDA clearance.",
      "Fact2: The experimental drug has patent protection.",
      "Fact3: The quality manager follows the protocol.",
      "Fact4: The trial for the experimental drug is terminated.",
      "Fact5: The experimental drug is submitted to the FDA.",
      "Fact6: The lab facility meets the requirements.",
      "Fact7: It does not hold that the experimental drug requires retesting.",
      "Fact8: The experimental drug does not require a special permit.",
      "Fact9: The experimental drug is not classified as an orphan drug.",
      "Fact10: The lab facility is not accredited by an agency.",
      "Fact11: The lab facility is not fined.",
      "Fact12: The lab facility is not reported to authorities.",
      "Fact13: The raw material is not suitable for use.",
      "Fact14: The experimental drug is not under surveillance.",
      "Fact15: The experimental drug does not have restricted distribution.",
      "Fact16: The production schedule is not delayed.",
      "Fact17: The production schedule is not on schedule.",
      "Fact18: The experimental drug is not fast-tracked.",
      "Fact19: The lab facility does not have compliant operations.",
      "Fact20: The lab facility does not have a valid license.",
      "Fact21: The lab facility is not operational.",
      "Fact22: The lab facility is not functional.",
      "Fact23: The lab facility does not exceed the standards."
    ]
  },
  "question": "The lab facility follows good manufacturing practices."
}